Novartis Consumer Health is voluntarily recalling the Triaminic Vapor Patch, due to the risk of serious harm caused by accidental ingestion. The patch is marketed as a cough suppressant, for use in children at least two years old. According to the label, the patch should be applied to the child’s throat or chest. However, such a location provides the opportunity for a child to remove and chew on the patch. Further, one of the patch’s scents, mentholated cherry, may entice a child to put it in their mouth. Ingestion of the ingredients of the patch could cause headache, vomiting or even seizures.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.